Atrial fibrillation in China

Chinese Medical Journal

Volumn 126, Issue 22, 2013, Pages 4366-4370

  Xu, Kai ^a   Liu, Xu ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; PIOGLITAZONE;

ABLATION THERAPY; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHINA; DISEASE CLASSIFICATION; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART RHYTHM; HEART VENTRICLE REMODELING; HUMAN; NOTE; OUTCOME ASSESSMENT; PREVALENCE; RADIOFREQUENCY ABLATION; RISK FACTOR; SINUS RHYTHM; THROMBOEMBOLISM; WAVELET ANALYSIS;

ATRIAL FIBRILLATION; CATHETER ABLATION; CHINA; HUMANS;

EID: 84887574009     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131078     Document Type: Note

References (46)

1. Roberts JD, Gollob MH. Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol 2010; 55: 705-712.
2. Zhang S. Atrial fibrillation in mainland China: epidemiology and current management. Heart 2009; 95: 1052-1055.
3. Franqui-Rivera H, Sotomonte JC. Update in atrial fibrillation. Bol Asoc Med P R 2011; 103: 67-71.
4. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 2008; 18: 209-216.
5. Chien KL, Su TC, Hsu HC, Chang WT, Chen PC, Chen MF, et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol 2010; 139: 173-180.
6. Wen-Hang QI. Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. Int J Cardiol 2005; 105: 283-287.
7. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
8. Schilling RJ, Kadish AH, Peters NS, Goldberger J, Davies DW. Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter. Eur Heart J 2000; 21: 550-564.
9. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
10. Li Y, Jian Z, Yang ZY, Chen L, Wang XF, Ma RY, et al. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Cardiology 2013; 124: 233-240.
11. He X, Gao X, Peng L, Wang S, Zhu Y, Ma H, et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 2011; 108: 164-175.
12. Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF, et al. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/ TRAF6 pathway in atrial fibroblasts. Exp Cell Res 2012; 318: 2105-2015.
13. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299: 251-254.
14. Xiao J, Liang D, Chen YH. The genetics of atrial fibrillation: from the bench to the bedside. Annu Rev Genomics Hum Genet 2011; 12: 73-96.
15. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75: 899-905.
16. Yang YQ, Xu YJ, Li RG, Qu XK, Fang WY, Liu X. Prevalence and spectrum of PITX2c mutations associated with familial atrial fibrillation. Int J Cardiol 2013. Epub ahead of print.
17. Huang RT, Xue S, Xu YJ, Zhou M, Yang YQ. A novel NKX2.5 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med 2013; 31: 1119-1126.
18. Wang XH, Huang CX, Wang Q, Li RG, Xu YJ, Liu X, et al. A novel GATA5 loss-of-function mutation underlies lone atrial fibrillation. Int J Mol Med 2013; 31: 43-50.
19. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101-e198.
20. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 2012; 9: 632-696.
21. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14: 1385-1413.
22. Huang CX, Zhang S, Ma CS, Yang YZ, Huang DJ, Cao KJ, et al. Current knowledge and management recommendation of atrial fibrillation 2012. Chin J Cardiac Arrhythmias (Chin) 2012; 16: 246-289.
23. Ma CS, Liu XP, Dong JZ. Radiofrequency catheter ablation of atrial fibrillation originating from the pulmonary veins: two cases report. Chin J Cardiac Pacing Electrophysiol (Chin) 1999; (03): 7-9.
24. Hu DY, Chen X, Ma CS. National survey on radiofrequency catheter ablation in China. Chin J Cardiac Arrhythmias (Chin) 2002; 6: 124-127.
25. Chen YH, Chen H, Wu Y, Hu D. Cardiac electrophysiology in China. Heart Rhythm 2007; 4: 862.
26. Huang CX, Zhang S, Ma CS, Cao KJ, Yang YZ, Liu X, et al. The registration study of catheter ablation in patients with atrial fibrillation in China. Chin J Cardiac Arrhythmias (Chin) 2006; 10: 468-474.
27. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000; 102: 2619-2628.
28. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48: 2340-2347.
29. Hocini M, Jaïs P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation 2005; 112: 3688-3696.
30. Hsu LF, Jaïs P, Hocini M, Sanders P, Scavée C, Sacher F, et al. Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol 2005; 28 Suppl 1: S106-S109.
31. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the lectrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2044-2053.
32. Li WJ, Bai YY, Zhang HY, Tang RB, Miao CL, Sang CH, et al. Additional ablation of complex fractionated atrial electrograms after pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis. Circ Arrhythm Electrophysiol 2011; 4: 143-148.
33. Wang X, Liu X, Shi H, Gu J, Sun Y, Zhou L, et al. Heart rhythm disorders and pacemakers: Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases. Heart 2009; 95: 1773-1783.
34. Lin Y, Ju W, Yang B, Chen H, Zhang F, Li M, et al. Does linear ablation and defragmentation really improve the success rate of persistent AF? Follow-up results and electrophysiological findings from 169 consecutive patients. Int J Cardiol 2012. Epub ahead of print.
35. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012; 60: 628-636.
36. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
37. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42: 185-97.
38. Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Williams-Andrews M, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm 2009; 6: 1403-1412.
39. Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol 2010; 21: 1071-1078.
40. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
41. Wang J, Li Y, Shi J, Han J, Xu C, Ma C, et al. Minimally invasive surgical versus catheter ablation for the long-lasting persistent atrial fibrillation. PLoS One 2011; 6: e22122.
42. Liu X, Tan HW, Wang XH, Shi HF, Li YZ, Li F, et al. Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial. Eur Heart J 2010; 31: 2633-2641.
43. Hu DY, Sun YH, Zhou ZQ, Li KB, Ni YB, Yang G, et al. Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study. Chin J Intern Med (Chin) 2003; 42: 157-161.
44. Zhou ZQ, Hu DY, Chen J, Zhang RH, Li KB, Zhao XL. An epidemiological survey of atrial fibrillation in China. Chin J Intern Med (Chin) 2004; 43: 491-494.
45. Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation 2011; 124: 2264-2274.
46. Gu J, Liu X, Wang X, Shi H, Tan H, Zhou L, et al. Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. Europace 2011; 13: 1256-1261.